Gastric bypass is a cost-saving procedure: Results from a comprehensive markov model

Obesity Surgery

Volumn 23, Issue 4, 2013, Pages 460-466

  Faria, Gil R ^a,b,c   Preto, John R ^a,b   Costa Maia, José ^b  

^a University of Porto   (Portugal)

^b São João Medical Center   (Portugal)

^c HSJ   (Portugal)

Author keywords

Cost effectiveness; Gastric bypass; Markov model; Obesity surgery

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL EVALUATION; COMORBIDITY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE CONTROL; GASTRIC BANDING; HEALTH CARE COST; HIDDEN MARKOV MODEL; HUMAN; MONTE CARLO METHOD; MORBID OBESITY; OBESITY; PATIENT CARE; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; STOMACH BYPASS; SURGICAL MORTALITY; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; COMORBIDITY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HEALTH EXPENDITURES; HUMANS; MALE; MARKOV CHAINS; MODELS, ECONOMIC; OBESITY, MORBID; PORTUGAL; QUALITY-ADJUSTED LIFE YEARS;

EID: 84876475366     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0816-8     Document Type: Article

References (41)

1. Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270-8.
2. Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118(4):599-606. discussion606-7.
3. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-52.
4. Johnson RJ, Johnson BL, Blackhurst DW, et al. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685-92.
5. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484-7.
6. Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214(6):892-900.
7. SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387-405.
8. Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646-53.
9. Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98(10):1422-9.
10. Chang S-H, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas. 2011;69(3):230-8.
11. Welbourn R, Pournaras D. Bariatric surgery: a cost-effective intervention for morbid obesity; functional and nutritional outcomes. Proc Nutr Soc. 2010;69(4):528-35.
12. Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010;16(7):e174-87.
13. Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg. 2009;19(11):1542-9.
14. Salem L, Devlin A, Sullivan SD, et al. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008;4(1):26-32.
15. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322-38.
16. Hunink MGM. Decision making in health and medicine. Cambridge, UK: Cambridge University Press; 2001.
17. Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993-1007.
18. Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567-74.
19. Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;2(13):39-46.
20. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76-9.
21. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416-23. discussion423-4.
22. McEwen LN, Coelho RB, Baumann LM, et al. The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population. Obes Surg. 2010;20(7):919-28.
23. Arias E. United States life tables, 2006. National vital statistics reports: from the Centers for Disease Control and Prevention (2010).
24. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199(4):543-51.
25. Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997;278(23):2069-74.
26. Pi-Sunyer FX. Type 2 diabetes outcomes. Obes Res. 2002;10 Suppl 1:22S-6S.
27. United States Environmental Protection Agency. Cardiovascular disease prevalence and mortality. Available from: http://cfpub.epa.gov/eroe/index.cfm? fuseaction=detail.viewInd&lv=list.listByAlpha&r=235292&subtop=381. Accessed 9 Jun 2012.
28. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56-65.
29. Davis WA, Knuiman MW, Hendrie D, et al. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the fremantle diabetes study. Intern Med J. 2006;36(3):155-61.
30. American Academy of Sleep Medicine. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine. Sleep. 2000;23(8):1017-8.
31. Gabriel SE, Crowson CS, Campion ME, et al. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24(4):719-25.
32. Potetz L. Cancer and medicare: a chartbook. Washington, DC: American Cancer Society; 2009.
33. National Institutes of Health. US Renal Data System (USRDS) annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health. http://www.usrds.org/adr.htm. 2010.
34. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113(6):491-8.
35. De Smedt D, De Cocker K, Annemans L, et al. A cost-effectiveness study of the community-based intervention '10,000 steps Ghent'. Public Health Nutr. 2012;15(3):442-51.
36. Pollock RF, Valentine WJ, Pilgaard T, et al. The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective. J Med Econ. 2011;14(1):36-46.
37. Padwal RS, Majumdar SR, Klarenbach S, et al. The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res. 2010;10:284.
38. Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16(11):1488-503.
39. Chevallier J-M, Daoud F, Szwarcensztein K, et al. Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB). Ann Chir. 2006;131(1):12-21.
40. Reis CEG, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index. Diabetes Technol Ther. 2012;14(4):365-72.
41. Deitel M. Bariatric surgery is a cost-saving for the healthcare system. Obes Surg. 2005;15(3):301-3.